A Study of Pemetrexed and Cisplatin, in Non Small Cell Lung Cancer

NCT01000480 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Small Cell Lung Cancer

Interventions

DRUG: Pemetrexed
DRUG: Cisplatin
RADIATION: Thoracic Radiotherapy

Sponsor

Eli Lilly and Company